ProPhase Labs, Inc. Quarterly report [Sections 13 or 15(d)]

Fair Value Measurements - Schedule of Fair Value Measurement Inputs and Valuation Techniques (Details)	Sep. 30, 2025 yr	Sep. 09, 2025 yr
Exercise price
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input		0.57
Derivative liability, measurement input	0.46
Expected term (years)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input		1
Derivative liability, measurement input	1
Expected stock price volatility
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input		0.992
Derivative liability, measurement input	0.992
Risk-free rate of interest
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input		0.036
Derivative liability, measurement input	0.036
Expected dividend yield (per share)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants and rights outstanding, measurement input		0
Derivative liability, measurement input	0